Sensitivity (+) |
FLT3-ITD
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835Y
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835A
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835E
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835H
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835N
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835S
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835V
|
Acute Lymphoid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3-ITD
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.D835Y
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.D835A
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.D835E
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.D835H
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.D835N
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.D835S
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.D835V
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3 p.I836del
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3-ITD
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3-ITD
|
Acute Myeloid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3 p.D835Y
|
Acute Myeloid Leukemia |
Gilteritinib
|
|
Sensitivity (+) |
FLT3-ITD
|
Acute Myeloid Leukemia |
Cytarabine,
Daunorubicin,
Midostaurin
|
|
Sensitivity (+) |
FLT3-ITD
|
Acute Myeloid Leukemia |
Midostaurin
|
|
Sensitivity (+) |
FLT3-ITD
|
Acute Myeloid Leukemia |
Midostaurin
|
|